About Bio X Cell
Bio X Cell is a Healthcare company based in Lebanon (United States) founded in 1997, and was acquired by Windjammer Capital Investors in December 2023. Antibodies and production services for in vivo applications are provided. The company has 23 employees. Its website bioxcell.com draws about 41 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 1997 and based in Lebanon, United States, Bio X Cell operates in the biotechnology sector. Antibodies for in vivo studies and functional assays are supplied, along with recombinant antibodies under the RecombiMAb line. Contract services for antibody production are also offered to support research and development needs in the life sciences field.
- Headquarters Lebanon, United States
- Employees 23
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bioxcell.com
- Social LinkedIn X Facebook
- Acquired by Windjammer Capital Investors (Dec 2023)
- Legal Name Bio X Cell
- Investors
- Employee Count23
- Acquired byWindjammer Capital Investors
(Dec 2023)
Investors in Bio X Cell
Bio X Cell has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Windjammer Capital Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are managed from Newport Beach, United States. | windjammercapital.com | Newport Beach, United States |
Investor details for Bio X Cell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bio X Cell
2 dated milestones of Bio X Cell across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Bio X Cell is founded.
- Exit Acquired by Windjammer Capital Investors.
Competitors of Bio X Cell
Bio X Cell has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| epitomics.com | 2001 | Burlingame, United States | $16.21M | Monoclonal antibody technology and products are developed by Epitomics. | ||
| vectorlabs.com | 1976 | Burlingame, United States | Labeling and detection reagents immunohistochemistry studies and other life science research applications |
Detailed competitors of Bio X Cell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bio X Cell
The website of Bio X Cell (bioxcell.com) receives about 40.6K visits a month.
- Monthly visits40.6K
▲ 3.2% vs previous month
Websites whose visitors overlap most with Bio X Cell. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
physiologyweb.com | physiologyweb.com | 100% | #490,465 | – | |
bio-rad-antibodies.com | bio-rad-antibodies.com | 88% | #287,074 | – | |
| toptipbio.com | 86% | #1,127,049 | View details | ||
creative-diagnostics.com | creative-diagnostics.com | 84% | #298,431 | – | |
| lsbio.com | 84% | 41.5K | #820,611 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 36 similar websites and full traffic analytics for Bio X Cell
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 36 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Bio X Cell (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bio X Cell
Complete news archive for Bio X Cell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bio X Cell
Bio X Cell was founded in 1997.
Bio X Cell is headquartered in Lebanon, United States.
Bio X Cell has 23 employees.
Founded in 1997 and based in Lebanon, United States, Bio X Cell operates in the biotechnology sector. Antibodies for in vivo studies and functional assays are supplied, along with recombinant antibodies under the RecombiMAb line. Contract services for antibody production are also offered to support research and development needs in the life sciences field.
Bio X Cell's top competitors include GenScript, Epitomics and Vector Laboratories.
Bio X Cell has 1 investor. Key investors include Windjammer Capital Investors.
Bio X Cell operates through Bio X Cell.
Yes. Bio X Cell was acquired by Windjammer Capital Investors in December 2023.